CSPC Pharmaceutical Group (HKSE:01093) EBIT per Share : HK$0.69 (TTM As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is CSPC Pharmaceutical Group EBIT per Share?

CSPC Pharmaceutical Group's EBIT per Share for the three months ended in Dec. 2023 was HK$0.17. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.69.

During the past 12 months, the average EBIT per Share Growth Rate of CSPC Pharmaceutical Group was 2.10% per year. During the past 3 years, the average EBIT per Share Growth Rate was 2.40% per year. During the past 5 years, the average EBIT per Share Growth Rate was 12.50% per year. During the past 10 years, the average EBIT per Share Growth Rate was 20.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for CSPC Pharmaceutical Group's EBIT per Share or its related term are showing as below:

HKSE:01093' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -52.9 Med: 21.85 Max: 162.3
Current: 2.4

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of CSPC Pharmaceutical Group was 162.30% per year. The lowest was -52.90% per year. And the median was 21.85% per year.

HKSE:01093's 3-Year EBIT Growth Rate is ranked worse than
59.41% of 850 companies
in the Drug Manufacturers industry
Industry Median: 7.95 vs HKSE:01093: 2.40

CSPC Pharmaceutical Group's EBIT for the three months ended in Dec. 2023 was HK$1,956 Mil.

CSPC Pharmaceutical Group EBIT per Share Historical Data

The historical data trend for CSPC Pharmaceutical Group's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group EBIT per Share Chart

CSPC Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.43

0.64

0.70

0.71

0.68

CSPC Pharmaceutical Group Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT per Share	Get a 7-Day Free Trial															0.19	0.17	0.18	0.18	0.17

CSPC Pharmaceutical Group EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

CSPC Pharmaceutical Group's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	8110.664	/	11873.031
=	0.68

CSPC Pharmaceutical Group's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	1956.368	/	11854.038
=	0.17

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.69

CSPC Pharmaceutical Group (HKSE:01093) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

CSPC Pharmaceutical Group EBIT per Share Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

CSPC Pharmaceutical Group (HKSE:01093) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (HKSE:01093) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

CSPCY:USA CHJTF:USA CVG:Germany

Address

No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035

Website

https://www.cspc.com.hk

CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

CSPC Pharmaceutical Group (HKSE:01093) Headlines

No Headlines